Research and experimental development on biotechnology
Registered Address
the glades festival way, festival park, stoke-on-trent, ST1 5SQ
Website
-
nugerontix limitedEstimated Valuation
£174.1k
Pomanda estimates the enterprise value of NUGERONTIX LIMITED at £174.1k based on a Turnover of £130.9k and 1.33x industry multiple (adjusted for size and gross margin).
nugerontix limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of NUGERONTIX LIMITED at £0 based on an EBITDA of £-315.2k and a 5.24x industry multiple (adjusted for size and gross margin).
nugerontix limitedEstimated Valuation
£65.5k
Pomanda estimates the enterprise value of NUGERONTIX LIMITED at £65.5k based on Net Assets of £36.6k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nugerontix LimitedOverview
Nugerontix Limited is a live company located in stoke-on-trent, ST1 5SQ with a Companies House number of 06136155. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in March 2007, it's largest shareholder is
roger corder
with a 46.5% stake. Nugerontix Limited is a established,
micro sized company, Pomanda has estimated its turnover at
£130.9k with
low
growth in recent years.
Pomanda's financial health check has awarded Nugerontix Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
1 Strong
4 Regular
4 Weak
Size
annual sales of £130.9k, make it smaller than the average company (£4.7m)
£130.9k - Nugerontix Limited
£4.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (13.8%)
3% - Nugerontix Limited
13.8% - Industry AVG
Production
with a gross margin of 56%, this company has a comparable cost of product (56%)
56% - Nugerontix Limited
56% - Industry AVG
Profitability
an operating margin of -247.6% make it less profitable than the average company (-3.9%)
-247.6% - Nugerontix Limited
-3.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (48)
1 - Nugerontix Limited
48 - Industry AVG
Pay Structure
on an average salary of £82.8k, the company has an equivalent pay structure (£82.8k)
£82.8k - Nugerontix Limited
£82.8k - Industry AVG
Efficiency
resulting in sales per employee of £130.9k, this is equally as efficient (£130.9k)
£130.9k - Nugerontix Limited
£130.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Nugerontix Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Nugerontix Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Nugerontix Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 45 weeks, this is more cash available to meet short term requirements (34 weeks)
45 weeks - Nugerontix Limited
34 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 48.9%, this is a similar level of debt than the average (49.5%)
48.9% - Nugerontix Limited
49.5% - Industry AVG
NUGERONTIX LIMITED financials
EXPORT
Nugerontix Limited's latest turnover from September 2024 is estimated at £130.9 thousand and the company has net assets of £36.6 thousand. According to their latest financial statements, Nugerontix Limited has 1 employee and maintains cash reserves of £30.8 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
130,852
127,094
130,761
119,211
113,831
5,717
7,837
2,161
29,740
Other Income Or Grants
Cost Of Sales
57,570
59,063
63,108
58,970
54,390
2,738
3,736
1,131
15,440
Gross Profit
73,282
68,031
67,653
60,241
59,442
2,979
4,101
1,030
14,300
Admin Expenses
397,323
693,078
687,599
348,340
176,523
33,163
9,950
17,699
1,944
12,331
16,452
Operating Profit
-324,041
-625,047
-619,946
-288,099
-117,081
-33,163
-6,971
-13,598
-1,944
-11,301
-2,152
Interest Payable
Interest Receivable
10,604
36,924
12,241
241
204
6
5
4
9
25
14
Pre-Tax Profit
-313,437
-588,123
-607,705
-287,858
-116,877
-33,157
-6,966
-13,594
-1,935
-11,276
-2,138
Tax
Profit After Tax
-313,437
-588,123
-607,705
-287,858
-116,877
-33,157
-6,966
-13,594
-1,935
-11,276
-2,138
Dividends Paid
Retained Profit
-313,437
-588,123
-607,705
-287,858
-116,877
-33,157
-6,966
-13,594
-1,935
-11,276
-2,138
Employee Costs
82,764
75,425
73,319
70,792
67,370
63,638
54,982
53,502
52,845
Number Of Employees
1
1
1
1
1
1
1
1
1
EBITDA*
-315,219
-613,445
-605,081
-288,099
-117,081
-30,943
-6,971
-13,598
-1,944
-11,301
-2,152
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
25,530
34,352
44,596
Intangible Assets
Investments & Other
2,625
2,625
2,625
2,625
2,625
2,625
Debtors (Due After 1 year)
Total Fixed Assets
28,155
36,977
47,221
2,625
2,625
2,625
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors
12,520
21,467
26,294
3,350
11,186
94
462
1,242
Cash
30,823
393,327
1,013,317
74,773
407,860
938
711
681
2,470
4,352
5,592
misc current assets
total current assets
43,343
414,794
1,039,611
78,123
419,046
1,032
1,173
1,923
2,470
4,352
5,592
total assets
71,498
451,771
1,086,832
80,748
421,671
3,657
1,173
1,923
2,470
4,352
5,592
Bank overdraft
Bank loan
Trade Creditors
34,250
1,714
2,980
766
6,730
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
34,939
101,775
148,713
34,924
53,739
53,098
18,368
10,886
819
total current liabilities
34,939
101,775
148,713
34,924
87,989
53,098
20,082
13,866
819
766
6,730
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
34,939
101,775
148,713
34,924
87,989
53,098
20,082
13,866
819
766
6,730
net assets
36,559
349,996
938,119
45,824
333,682
-49,441
-18,909
-11,943
1,651
3,586
-1,138
total shareholders funds
36,559
349,996
938,119
45,824
333,682
-49,441
-18,909
-11,943
1,651
3,586
-1,138
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
-324,041
-625,047
-619,946
-288,099
-117,081
-33,163
-6,971
-13,598
-1,944
-11,301
-2,152
Depreciation
8,822
11,602
14,865
Amortisation
2,220
Tax
Stock
Debtors
-8,947
-4,827
22,944
-7,836
11,092
-368
-780
1,242
Creditors
-34,250
34,250
-1,714
-1,266
2,980
-766
-5,964
6,730
Accruals and Deferred Income
-66,836
-46,938
113,789
-18,815
641
34,730
7,482
10,067
819
Deferred Taxes & Provisions
Cash flow from operations
-373,108
-655,556
-514,236
-333,328
-93,282
2,441
25
-1,793
-1,891
-17,265
4,578
Investing Activities
capital expenditure
-1,358
-59,461
-2,220
Change in Investments
2,625
cash flow from investments
-1,358
-59,461
-4,845
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1,500,000
500,000
2,625
16,000
1,000
interest
10,604
36,924
12,241
241
204
6
5
4
9
25
14
cash flow from financing
10,604
36,924
1,512,241
241
500,204
2,631
5
4
9
16,025
1,014
cash and cash equivalents
cash
-362,504
-619,990
938,544
-333,087
406,922
227
30
-1,789
-1,882
-1,240
5,592
overdraft
change in cash
-362,504
-619,990
938,544
-333,087
406,922
227
30
-1,789
-1,882
-1,240
5,592
nugerontix limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for nugerontix limited. Get real-time insights into nugerontix limited's credit score, group structure and payment trends.
Perform a competitor analysis for nugerontix limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in ST1 area or any other competitors across 12 key performance metrics.
nugerontix limited Ownership
NUGERONTIX LIMITED group structure
Nugerontix Limited has no subsidiary companies.
Ultimate parent company
NUGERONTIX LIMITED
06136155
NUGERONTIX LIMITED Shareholders
The largest shareholders in Nugerontix Limited include Roger Corder and Cambrian Biopharma Inc.
roger corder
46.53%
cambrian biopharma inc
38.91%
susan corder
7.54%
kevin george bilyard
7.01%
nugerontix limited directors
Nugerontix Limited currently has 3 directors.
The longest serving directors include
Professor Roger Corder (Mar 2007) and
Mr Kevin Bilyard (Mar 2007).
72110 - Research and experimental development on biotechnology
incorporation date
March 2007
age
18
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
September 2024
previous names
flavosante foods limited (October 2012)
flavosante limited (June 2011)
accountant
-
auditor
-
address
the glades festival way, festival park, stoke-on-trent, ST1 5SQ
Bank
-
Legal Advisor
-
nugerontix limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to nugerontix limited.
nugerontix limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NUGERONTIX LIMITED. This can take several minutes, an email will notify you when this has completed.
nugerontix limitedCompanies House Filings - See Documents
